Large-scale testing (Phase 3)Study completedNCT05349617
What this trial is testing
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
Who this might be right for
Chikungunya Virus
Bavarian Nordic 413
Showing 20 of 87 results